Lunit Cancer Screening’s Post

Prof. Dr. Constantinos Zamboglou, MHBA, Medical Director of our Hospital, was invited by Prof. Dr. Sue Yom the Editor-in-Chief of the IJROBP The Red Journal to discuss recent innovations in prostate cancer radiotherapy with experts from the US, Canada, and Australia. The discussion focused on the integration of high-precision radiotherapy and advanced medical imaging technologies, which are set to significantly improve the quality of life for patients following treatment. At German Medical Institute, we are proud to lead in personalized medicine, approaching healthcare with a holistic perspective. We view each individual as unique, customizing treatments to their specific needs and aspirations. By embracing the latest advancements, we are shaping new pathways to better health, ensuring the best possible outcomes for every patient’s future. The podcast can be found at the following link: https://lnkd.in/euZpaNYw #Radiotherapy #ProstateCancer #PersonalizedMedicine #HealthcareInnovation #MedicalExcellence #GermanMedicalInstitute #FutureOfMedicine Ίδρυμα Έρευνας και Καινοτομίας/Research and Innovation Foundation

Dr. Ivan Colon of New York Health is revolutionizing prostate cancer care with the Promaxo MRI System. This innovative technology has given him the confidence to deliver high-quality care without the need for placing an ultrasound or probe in the rectum, significantly enhancing patient comfort. This advancement is particularly beneficial for patients who may not have a rectum, making procedures easier and more accessible. Dr. Colon emphasizes that using the Promaxo MRI System simplifies the targeting of the prostate, enabling him to complete procedures with greater ease and precision. By prioritizing patient comfort while maintaining high standards of care, Dr. Colon continues to lead the way in precision patient care. #ProstateCare #PromaxoMRI #PatientComfort #InnovativeHealthcare #PrecisionMedicine

This year, the PMNET Forum (Riga, Latvia) —known for advancing precision medicine—focused on innovative technologies that transform patient care. Among the highlights was Marie Bernkopf, who presented on #LiquidBiopsies for neuroblastoma patients, part of the international Monalisa project. ℹ️ #Neuroblastoma, the most common solid tumor in infants, has devastating relapse rates, especially in high-risk patients. The current monitoring methods, including MRI and bone marrow samples, are invasive and stressful for children. Marie’s work with Monalisa is exploring how liquid biopsies can change the game by detecting relapse earlier—sometimes up to 17 weeks before traditional methods❗ 🎯 With Monalisa, the aim is clear: revolutionize patient monitoring, improve outcomes, and ultimately, make liquid biopsies a standard of care in neuroblastoma treatment. The trial will also develop digital tools to assist oncologists and improve patient quality of life. #research #PMNETforum2024

The team at Barreleye (Korea), the Quantitative Ultrasound Software company is thrilled to share the results of their Vis-BUS (breast cancer application) confirmatory clinical trial conducted at Seoul National University Hospital. Despite the fact that the doctors at Seoul National University Hospital are very experienced and accurate in performing breast ultrasound, Vis-BUS improved the accuracy of the screening and reduced the observation time. * The AUC increased from 0.907 to 0.937 * The observation time decreased from 14 seconds to 4 seconds. * The users were also very positive about the ease of use. #breastcancerscreening #ultrasound #diagnosticimaging #MedicalAI #quantitativeultrasound #barreleye #Medtech #AI #healthcare

🌟Based on Grand View Research, Inc’s AI in Healthcare market Size & Trends Report, the global AI healthcare market is booming, valued at $19.27 billion in 2023 and expected to grow rapidly. Studies show AI can outperform human radiologists, reducing false positives and negatives in breast cancer detection. AI can also predict acute kidney injury hours before it occurs, enhancing patient outcomes. At Oxipit, we’re excited to be part of this transformation, helping to improve diagnostics and patient care. Read the full report: https://lnkd.in/eJSSBvnt. #AIinHealthcare #Radiology #Innovation #PatientCare #Oxipit

At GE HealthCare, we aim to provide #HealthcareThatEmpowers. This #ProstateCancerAwarenessMonth we want to highlight the power of early intervention by encouraging men to be proactive about their prostate health and educating the public on the importance of this matter. The theme of "putting pressure on prostate cancer" emphasizes the urgency of combating this disease through empowerment, knowledge, screening, and imaging techniques like MRI-ultrasound guided prostate biopsies. Add artificial intelligence (AI) to the mix, and see the benefits multiply. Prostate Volume Assist (PVA) is our AI-enabled software feature for faster prostate measurements in ultrasound that benefits the surgeon and the patient.* Surgeons can achieve faster, more accurate and reproducible results leading to increased diagnostic confidence, and patients can experience shorter exam times, fewer unnecessary procedures, and earlier diagnoses.1 Learn more about the impact of PVA: https://lnkd.in/dSGyYhcQ #GEHealthCare #Prostate

At #RSNA2024 Radiological Society of North America (RSNA) today, we’re showcasing advancements in chest X-ray #AI #technology and its role in transforming early #lungcancer detection and care coordination.    Spotlight Sessions:  • The Power of Chest X-ray AI and Early Lung Cancer Detection  Presented by Prof. David Lowe, Professor of Health Innovation, University of Glasgow • The Potential of AI in #EarlyDetection of #Lung #Cancer: The Unbiased Peer Review  Presented by Dr. Bruno Hochhegger, Thoracic Radiologist, University of Florida, and Dr. Amit Gupta, Section Chief of Cardiothoracic Imaging, University Hospitals Cleveland Medical Center Inc.   Join us to explore how AI is driving #innovation in #lunghealth and empowering clinicians with tools for #earlydiagnosis and improved outcomes.    #LungHealth #AIInHealthcare #RSNA #LungCancerDetection #InnovationInCare 

At GE HealthCare, we aim to provide #HealthcareThatEmpowers. This #ProstateCancerAwarenessMonth we want to highlight the power of early intervention by encouraging men to be proactive about their prostate health and educating the public on the importance of this matter. The theme of "putting pressure on prostate cancer" emphasizes the urgency of combating this disease through empowerment, knowledge, screening, and imaging techniques like MRI-ultrasound guided prostate biopsies. Add artificial intelligence (AI) to the mix, and see the benefits multiply. Prostate Volume Assist (PVA) is our AI-enabled software feature for faster prostate measurements in ultrasound that benefits the surgeon and the patient.* Surgeons can achieve faster, more accurate and reproducible results leading to increased diagnostic confidence, and patients can experience shorter exam times, fewer unnecessary procedures, and earlier diagnoses.1 Learn more about the impact of PVA: https://hubs.la/Q02Q0CD30 #GEHealthCare #Prostate

BREAKING NEWS contextflow Set to Secure Europe’s First Radiology AI Reimbursement Contract This pioneering agreement seeks to improve lung cancer detection for patients and set a precedent for AI adoption in medical imaging across Europe. "With the support of Healthy Hub and IKK Südwest, we’re forging new paths by creating a radiology-specific reimbursement model that prioritizes quality care through advanced AI diagnostics. Our goal is to improve patient outcomes by making comprehensive and reliable lung cancer and disease detection accessible to radiologists. In turn, this enables more precise and proactive detection, which helps enhance operational efficiency and reduce unnecessary costs across the healthcare system" said Markus Holzer, CEO at contextflow. Congrats Markus and team for this incredible milestone! Read the full news: https://lnkd.in/gyX-4UYs #reimbursment #radiology #lungcancer #cancer #healthtech #innovation #insurance #wearenina

Combining cutting-edge technology with a commitment to advancing patient care by making sure that technology is at a price point that is readily accessible for most hospitals globally, Body Vision Medical is revolutionizing the way we visualize and navigate lung procedures. 🫁💡 LungVision's AI Tomography and augmented fluoroscopy real-time imaging 3D enhances precision and efficiency of the lung nodule biopsy procedure, empowering clinicians to diagnose lung cancer cost-effectively and feasibly at an earlier stage. See below the 4 key aspects of #LungVision that set it apart from other navigational bronchoscopy technologies... #lungcancer #advancedbronchoscopy #innovation #healthcaretechnology